Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874716-25-000150
Filing Date
2025-09-03
Accepted
2025-09-03 17:56:31
Documents
1
Period of Report
2025-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1756936587.html 4  
1 FORM 4 wk-form4_1756936587.xml 4 7101
  Complete submission text file 0000874716-25-000150.txt   8637
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Issuer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O IDEXX LABORATORIES, INC. ONE IDEXX DRIVE WESTBROOK ME 04092
Business Address
Smith Martin Alexander (Reporting) CIK: 0001621358 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19271 | Film No.: 251291304